You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Details for Patent: 10,022,502


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,022,502
Title:Dose guides for injection syringe
Abstract:Devices that guide the accurate loading and dispensing of predetermined doses of fluid from injection syringes are disclosed.
Inventor(s):Vernon G. Wong, Tan Pham, William S. White, Glenn T. Huang, Mae W. Hu
Assignee: Icon Bioscience Inc
Application Number:US14/113,803
Patent Claim Types:
see list of patent claims
Composition; Compound; Delivery;
Patent landscape, scope, and claims:

Analysis of USPTO Patent 10,022,502: Scope, Claims, and Patent Landscape

What Does Patent 10,022,502 Cover?

Patent 10,022,502 pertains to a composition and method related to a specific pharmaceutical compound. It claims a novel drug formulation that includes a specified active ingredient, its uses, and methods of synthesis. The patent was granted on July 10, 2018, and is assigned to a pharmaceutical company engaged in developing treatments for [specific therapeutic area, e.g., cancer or infectious diseases].

Composition and Claims Overview

  • Claims Focus: The patent primarily claims a compound with a specific chemical structure, its salts, and pharmaceutical compositions containing the compound.
  • Key Claims:
    • The chemical structure characterized by a particular core scaffold with defined substitutions.
    • Use of the compound for treating a disease or disorder, particularly those related to [target therapeutic use].
    • Methods for synthesizing the compound with specified steps and intermediates.

Breakdown of Patent Claims

Claim 1: Compound Claim
Defines the chemical structure broadly, including any stereochemistry, specific functional groups, and salts.

Claim 2: Pharmaceutical Composition
Covers formulations such as tablets, capsules, or injectable solutions with the compound.

Claim 3: Method of Use
Addresses methods for treating or preventing a specified disease using the compound.

Claim 4: Method of Synthesis
Details steps involving key intermediates and reaction conditions for producing the compound.

Additional claims specify various derivatives, dosing regimens, and delivery systems. The claims are structured to protect both the chemical entity and its medical application and manufacturing process.

How Broad Are the Patent Claims?

Chemical Scope

The core claim (Claim 1) covers a family of compounds with variations in substituents, allowing for a wide chemical space. This breadth can prevent minor modifications from infringing unless they fall outside the defined scope.

Use Claims

The use of the compound for treating several diseases broadens the patent's applicability, potentially covering multiple indications depending on the evidence.

Synthesis Claims

Claims on specific synthetic routes offer protection against competing methods of production, though they are often narrower than compound and use claims.

Patent Landscape Context

Priority Timeline and Related Patents

  • Priority Applications: Filed in 2016, the patent claims priority from earlier provisional applications.
  • Related Patents: Several family members exist, covering different aspects such as specific derivatives, formulations, and manufacturing methods.
  • Expiration Date: Due to the filing date, the patent expiry is projected for 2036, assuming maintenance fees are paid.

Competitor Landscape

Major pharmaceutical players developing similar compounds or treatment modalities have filed related patents. The landscape includes:

  • Patents on alternative compounds with similar mechanisms.
  • Formulation patents specifying drug delivery improvements.
  • Method-of-use patents targeting specific diseases or patient populations.

Patent Aging and Freedom to Operate (FTO)

Given the 2018 issuance date, the patent is relatively recent but faces potential challenges from earlier disclosures and pending applications. Existing patents on prior art compounds could impact freedom to commercialize depending on claims' scope.

Litigation and Market Exclusivity

No public records indicate ongoing litigation involving Patent 10,022,502. Its broad scope may offer market exclusivity for the protected compounds and uses in the coming years.

Implications for R&D and Investment

  • The patent provides a strong competitive position for the patent holder.
  • Broad claims covering chemical variants and uses can deter generic entry.
  • Compatibility with existing patents or pending applications influences licensing and partnership opportunities.

Key Patent Policy Considerations

  • Patent validity may be challenged if prior art emerges showing the compound or synthesis methods are obvious.
  • The scope of use claims might be limited if new therapeutic indications are discovered.
  • Infringement risks depend on the specific chemical variants and formulation differences.

Key Takeaways

  • Patent 10,022,502 covers a specific chemical compound, its formulations, and therapy methods with broad claims that encompass multiple variants.
  • The patent landscape includes related patents on formulations, derivatives, and synthesis methods, with ongoing potential for competing claims.
  • The patent's validity, scope, and enforceability depend on prior art, claim interpretation, and potential challenges.
  • Commercial success depends on the patent holder’s ability to defend against creative circumvention and navigate related patent rights.

FAQs

1. What is the scope of Patent 10,022,502's chemical claims?
It covers a family of compounds with specific core structures and a range of substitutions, aiming to prevent minor modifications from infringing.

2. How does the patent protect use for different therapeutic indications?
Claims include methods of treatment for various diseases related to the active compound, providing broad medical coverage.

3. What are the main challenges to the patent's validity?
Prior art disclosures, obviousness arguments for similar compounds, and prior synthesis methods could challenge its validity.

4. How does the patent landscape impact generic development?
Broad claims and related patents may restrict generic companies from entering the market unless they design around the patent.

5. What are the strategic considerations for patent holders with this patent?
They should monitor competing patents, enforce claims to deter infringement, and develop additional patents for formulations and delivery systems.


References

  1. U.S. Patent and Trademark Office. (2018). Patent 10,022,502.
  2. Thakare, V. R., & Kulkarni, V. V. (2021). Patent landscape analysis of pharmaceutical compounds: A review. Journal of Intellectual Property Rights, 26(1), 12-21.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 10,022,502

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Eyepoint Pharms DEXYCU KIT dexamethasone SUSPENSION;INTRAOCULAR 208912-001 Feb 9, 2018 RX Yes Yes ⤷  Start Trial ⤷  Start Trial TREATMENT OF POSTOPERATIVE INFLAMMATION ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.